Optaloc

Optaloc Uses, Dosage, Side Effects, Mechanism of Action, How Long Does it Take to Work? Optaloc is a brand name. Its generic name is Betaxolol.

Optaloc

Optaloc is a medication in the class of cardio-selective beta-blockers used in the treatment of hypertension, angina, tachyarrhythmias, and glaucoma. Used orally and topically, Optaloc is a drug widely prescribed to treat certain heart conditions.

Uses For

Optaloc is primarily used in the treatment of hypertension by blocking the beta receptors in the body. Additionally, Optaloc is also used to treat arrhythmias, angina, and glaucoma. By decreasing the heart rate and cardiac contractility, it helps to reduce blood pressure and prevent heart attacks.

Mechanism of Action

Optaloc works by decreasing the number of beta receptors in the body, thus reducing the activity of the heart, resulting in a slower heart rate. Optaloc also inhibits the hormone adrenaline from binding to these beta receptors, further reducing the activity of the heart.

How Long Does it Take to Work?

The effects of Optaloc start to take effect within 20 minutes of administration and should reach peak effect within an hour after ingestion.

Absorption

Optaloc is rapidly absorbed after the oral administration. Its bioavailability is more than 90%.

Route of Elimination

Optaloc is eliminated primarily in the urine.

Dosage

For hypertension, the initial dose is 5mg two times a day. The dosage may be increased up to 40mg two times a day, depending on the patient’s response. For arrhythmias, the initial dose is 5mg two times a day. The dosage may be increased up to 20mg two times a day, depending on the patient’s response. For glaucoma, the initial dose is 2.5mg two times a day. The dosage may be increased up to 20mg two times a day, depending on the patient’s response.

Administration

Optaloc can be taken orally or administered as an ophthalmic solution.

Side Effect

The most common side effects associated with Optaloc include dizziness, headaches, lethargy, nausea, and cold hands and feet.

Toxicity

Optaloc is generally well tolerated. Overdose of Optaloc can cause undesired bradycardia, hypotension, and congestive heart failure.

Precaution

Patients should inform the health care provider of any pre-existing conditions before taking Optaloc, such as diabetes, heart failure, kidney disease, or liver disease. Chronic use of Optaloc can lead to drug tolerance, so it should be used with caution. Optaloc can also interact with other medications, so patients should ensure to inform the health care provider of all medications they are taking before taking Optaloc.

Interaction

Patients should inform the health care provider of all medications they are taking before taking Optaloc. Optaloc may interact with certain medications and supplements to produce undesired effects. Patients with any pre-existing conditions should inform the health care provider of any medications they may be taking.

Disease Interaction

Due to its effect on the heart, there is a risk of adverse reactions in patients with underlying heart diseases while taking Optaloc. Patients with diabetes, heart failure, or kidney disease should exercise caution while taking Optaloc as it can increase the risks associated with the condition.

Drug Interaction

Optaloc may interact with certain medications like calcium-channel blockers, vasodilators, clonidine, and other beta-blockers. Optaloc can also interact with certain supplements like omega-3 fatty acids, St. John’s Wort, Ginkgo biloba, and other products.

Food Interactions

Optaloc should not be taken with food. Food can reduce the absorption of Optaloc and may increase the risk of adverse reactions.

Pregnancy Use

The safety of Optaloc during pregnancy has not been established. It is advised that pregnant women should consult a healthcare provider before taking Optaloc.

Lactation Use

It is not recommended to take Optaloc while breastfeeding as it can pass into the breast milk and affect the baby.

Acute Overdose

Overdose of Optaloc can lead to unwanted symptoms such as bradycardia, hypotension, and congestive heart failure. In case of an overdose, the patient should seek immediate medical attention.

Contraindication

Optaloc is contraindicated in patients with severe bradycardia, heart block, sick sinus syndrome, and bronchial asthma.

Use Direction

Optaloc should be taken as directed by the health care provider. It should be taken with or without food, depending on the prescriber's instructions. The administration of Optaloc may be modified according to the patient's response, and the dosage should not be altered without consulting with the healthcare provider.

storage Condition

Optaloc should be stored at room temperature, away from light and moisture.

Volume of Distribution

Optaloc has a wide distribution in the body. It is rapidly absorbed after the oral administration with more than 90% bioavailability.

Half Life

The half-life of Optaloc is approximately 4-9 hours.

Clearance

The clearance of Optaloc is 500-1,280 mL/min.

Here you find in details version of Optaloc

Some Frequently Asked Questions About Optaloc

https://www.medicinesfaq.com/brand/optaloc, http://classyfire.wishartlab.com/tax_nodes/C0000000, http://classyfire.wishartlab.com/tax_nodes/C0002448, http://classyfire.wishartlab.com/tax_nodes/C0000134, http://classyfire.wishartlab.com/tax_nodes/C0000139, http://classyfire.wishartlab.com/tax_nodes/C0000139, http://classyfire.wishartlab.com/tax_nodes/C0004742, http://classyfire.wishartlab.com/tax_nodes/C0002341, http://classyfire.wishartlab.com/tax_nodes/C0000128, http://classyfire.wishartlab.com/tax_nodes/C0001661, http://classyfire.wishartlab.com/tax_nodes/C0001897, http://classyfire.wishartlab.com/tax_nodes/C0002228, http://classyfire.wishartlab.com/tax_nodes/C0001167, http://classyfire.wishartlab.com/tax_nodes/C0004557, http://classyfire.wishartlab.com/tax_nodes/C0004150, https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:3082, http://www.hmdb.ca/metabolites/HMDB0014341, http://www.genome.jp/dbget-bin/www_bget?cpd:C06849, https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=2369, https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46506041, https://www.chemspider.com/Chemical-Structure.2279.html, http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50405521, https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1520, https://www.ebi.ac.uk/chebi/searchId.do?chebiId=3082, https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL423, http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP000305, http://www.pharmgkb.org/drug/PA448611, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=549, http://www.rxlist.com/cgi/generic3/betaxolol.htm, https://www.drugs.com/cdi/betaxolol-drops.html, https://en.wikipedia.org/wiki/Betaxolol,